|
|
| Line 19: |
Line 19: |
| |
| legal_status = |
|
| legal_status = |
| |
| routes_of_administration = }} |
|
| routes_of_administration = }} |
| − |
'''Loxapine''' (sold as '''Loxapac'''®, '''Loxitane'''®) is a [[typical antipsychotic]] [[medication]], used primarily in the treatment of [[schizophrenia]]. It is a member of the [[dibenzodiazepine]] family and structurally related to [[clozapine]]. Several researchers have argued that Loxapine may behave as an [[atypical antipsychotic]] (PMID 10340686). |
+ |
'''Loxapine''' (sold as '''Loxapac''', '''Loxitane''') is a [[typical antipsychotic]] [[medication]], used primarily in the treatment of [[schizophrenia]]. It is a member of the [[dibenzoxazepine]] class and as a [[dibenzazepine]] [[Derivative (chemistry)|derivative]], it is structurally related to [[clozapine]] (which belongs to the chemically closely akin class of [[dibenzodiazepines]]). Several researchers have argued that Loxapine may behave as an [[atypical antipsychotic]] <ref name="titleDoes loxapine have atypical properties? Clinical...[J Clin Psychiatry. 1999] - PubMed Result">{{cite web |url=http://www.ncbi.nlm.nih.gov/pubmed/10340686 |title=Does loxapine have "atypical" properties? Clinical evidence. [J Clin Psychiatry. 1999] - PubMed Result |accessdate= |format= |work=}}</ref>. |
| |
|
|
|
| − |
Loxapine may be metabolized by N-demethylation to [[amoxapine]], a [[tetracyclic antidepressant]] (PMID 1860915). |
+ |
Loxapine may be metabolized by N-demethylation to [[amoxapine]], a [[tricyclic antidepressant]] <ref name="titleSimultaneous quantitation of loxapine, amoxapine a...[J Chromatogr. 1991] - PubMed Result">{{cite web |url=http://www.ncbi.nlm.nih.gov/pubmed/1860915 |title=Simultaneous quantitation of loxapine, amoxapine a...[J Chromatogr. 1991] - PubMed Result |accessdate= |format= |work=}}</ref>. |
| |
+ |
|
| |
+ |
==Precautions== |
| |
+ |
|
| |
+ |
Care should be taken with consumption. At least 3 cases were reported of loxapine succinate abuse.<ref name="pmid6694719">{{cite journal |
| |
+ |
|author=Sperry L, Hudson B, Chan CH |
| |
+ |
|title=Loxapine abuse |
| |
+ |
|journal=The New England Journal of Medicine |
| |
+ |
|volume=310 |
| |
+ |
|issue=9 |
| |
+ |
|pages=598 |
| |
+ |
|year=1984 |
| |
+ |
|month=March |
| |
+ |
|pmid=6694719 |
| |
+ |
|doi= |
| |
+ |
|url= |
| |
+ |
|issn= |
| |
+ |
|accessdate=2009-06-20 |
| |
+ |
}}</ref> |
| |
+ |
|
| |
+ |
An overdose accident happened with a 8 year old child who swallowed a 375 miligram loxitane pill. 30 minutes later it was treated with activated charcoal. The child became drowsy and was asleep but arousable 1 hour after ingestion. The degree of sedation appeared to peak after 3.75 hours and the child was discharged about 20 hours after ingestion.<ref name="pmid9499203">{{cite journal |
| |
+ |
|author=Tarricone NW |
| |
+ |
|title=Loxitane overdose |
| |
+ |
|journal=Pediatrics |
| |
+ |
|volume=101 |
| |
+ |
|issue=3 Pt 1 |
| |
+ |
|pages=496 |
| |
+ |
|year=1998 |
| |
+ |
|month=March |
| |
+ |
|pmid=9499203 |
| |
+ |
|doi= |
| |
+ |
|url=http://pediatrics.aappublications.org/cgi/pmidlookup?view=long&pmid=9499203 |
| |
+ |
|issn= |
| |
+ |
|accessdate=2009-06-20 |
| |
+ |
}}</ref> |
| |
|
|
|
| |
== Side effects == |
|
== Side effects == |
| − |
[[Adverse drug reaction|Side effects]] include [[tardive dyskinesia]], [[neuroleptic malignant syndrome]], [[extrapyramidal system|extrapyramidal side effects]], [[tremor]] and [[sedation]]. |
+ |
{{see|Typical antipsychotic}} |
| |
+ |
The most significant side-effects of loxapine are excessive salivation and indifference to surroundings. Loxapine, if administered to individuals without schizophrenia, causes emotional quieting and insensitivity. In persons with psychosis, it may control aggressive behaviour and restlessness, and reduce the severity of hallucinations and delusions. |
| |
+ |
Other [[Adverse drug reaction|Side effects]] include [[tardive dyskinesia]], [[neuroleptic malignant syndrome]], [[extrapyramidal system|extrapyramidal side effects]], [[tremor]], [[gynecomastia]] and [[sedation]]. |
| |
+ |
|
| |
+ |
==Dosage== |
| |
+ |
The typical starting dosage is 10mg twice daily; usual dose range 30-50mg twice daily; maximum recommended dosage is 250mg per day. |
| |
+ |
|
| |
+ |
A brief review of loxapine<ref name="pmid1747161">{{cite journal |
| |
+ |
|author= |
| |
+ |
|title=Clozapine and loxapine for schizophrenia |
| |
+ |
|journal=Drug and Therapeutics Bulletin |
| |
+ |
|volume=29 |
| |
+ |
|issue=11 |
| |
+ |
|pages=41–2 |
| |
+ |
|year=1991 |
| |
+ |
|month=May |
| |
+ |
|pmid=1747161 |
| |
+ |
|doi= |
| |
+ |
|url= |
| |
+ |
|issn= |
| |
+ |
|accessdate=2009-06-20 |
| |
+ |
}}</ref> found no conclusive evidence that it was particularly effective in patients with paranoid schizophrenia. A subsequent systematic review considered that the limited evidence did not indicate a clear difference in its effects from other antipsychotics.<ref name="pmid17943763">{{cite journal |
| |
+ |
|author=Chakrabarti A, Bagnall A, Chue P, ''et al.'' |
| |
+ |
|title=Loxapine for schizophrenia |
| |
+ |
|journal=Cochrane Database of Systematic Reviews (Online) |
| |
+ |
|volume= |
| |
+ |
|issue=4 |
| |
+ |
|pages=CD001943 |
| |
+ |
|year=2007 |
| |
+ |
|pmid=17943763 |
| |
+ |
|doi=10.1002/14651858.CD001943.pub2 |
| |
+ |
|url= |
| |
+ |
|issn= |
| |
+ |
|accessdate=2009-06-20 |
| |
+ |
}}</ref> |
| |
+ |
|
| |
+ |
==References== |
| |
+ |
{{reflist}} |
| |
+ |
|
| |
+ |
==External links== |
| |
+ |
*[http://www.medscape.com/druginfo/monograph?cid=med&drugid=14375&drugname=Loxapine+Succinate+Oral&monotype=monograph&secid=3 Product monograph] from Medscape (free registration required). |
| |
|
|
|
| |
{{Antipsychotics}} |
|
{{Antipsychotics}} |
| |
+ |
{{Serotonergics}} |
| |
+ |
{{Dopaminergics}} |
| |
+ |
{{Piperazines}} |
| |
|
|
|
| |
<!--Categories--> |
|
<!--Categories--> |
| |
+ |
[[Category:Minor tranquilizers]] |
| |
+ |
[[Category:Piperazines]] |
| |
[[Category:Typical antipsychotics]] |
|
[[Category:Typical antipsychotics]] |
| |
|
|
|
| |
+ |
|
| |
+ |
<!-- |
| |
+ |
[[fr:Loxapine]] |
| |
+ |
--> |
| |
{{enWP|Loxapine}} |
|
{{enWP|Loxapine}} |
Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological:
Behavioural genetics ·
Evolutionary psychology ·
Neuroanatomy ·
Neurochemistry ·
Neuroendocrinology ·
Psychoneuroimmunology ·
Physiological Psychology ·
Psychopharmacology
Loxapine (sold as Loxapac, Loxitane) is a typical antipsychotic medication, used primarily in the treatment of schizophrenia. It is a member of the dibenzoxazepine class and as a dibenzazepine derivative, it is structurally related to clozapine (which belongs to the chemically closely akin class of dibenzodiazepines). Several researchers have argued that Loxapine may behave as an atypical antipsychotic [1].
Loxapine may be metabolized by N-demethylation to amoxapine, a tricyclic antidepressant [2].
Precautions
Edit
Care should be taken with consumption. At least 3 cases were reported of loxapine succinate abuse.[3]
An overdose accident happened with a 8 year old child who swallowed a 375 miligram loxitane pill. 30 minutes later it was treated with activated charcoal. The child became drowsy and was asleep but arousable 1 hour after ingestion. The degree of sedation appeared to peak after 3.75 hours and the child was discharged about 20 hours after ingestion.[4]
Side effects
Edit
- Further information: Typical antipsychotic
The most significant side-effects of loxapine are excessive salivation and indifference to surroundings. Loxapine, if administered to individuals without schizophrenia, causes emotional quieting and insensitivity. In persons with psychosis, it may control aggressive behaviour and restlessness, and reduce the severity of hallucinations and delusions.
Other Side effects include tardive dyskinesia, neuroleptic malignant syndrome, extrapyramidal side effects, tremor, gynecomastia and sedation.
The typical starting dosage is 10mg twice daily; usual dose range 30-50mg twice daily; maximum recommended dosage is 250mg per day.
A brief review of loxapine[5] found no conclusive evidence that it was particularly effective in patients with paranoid schizophrenia. A subsequent systematic review considered that the limited evidence did not indicate a clear difference in its effects from other antipsychotics.[6]
References
Edit
External links
Edit
| Psycholeptics: antipsychotics (N05A)
|
| Phenothiazine typical antipsychotics
| Chlorpromazine • Fluphenazine • Mesoridazine • Perphenazine • Prochlorperazine • Promazine • Thioridazine/Sulforidazine • Trifluoperazine
|
| Other typical antipsychotics
| Indoles (Molindone) • Butyrophenones (Azaperone, Benperidol, Droperidol, Haloperidol) • Thioxanthenes (Flupentixol, Chlorprothixene, Thiothixene, Zuclopenthixol) • diphenylbutylpiperidines (Fluspirilene, Penfluridol, Pimozide) • other (Loxapine)
|
| Atypical antipsychotics
| Butyrophenones (Melperone) • Indoles (Sertindole, Ziprasidone) • Benzamides (Sulpiride, Remoxipride, Amisulpride) • diazepines/oxazepines/thiazepines (Clozapine, Olanzapine, Quetiapine) • other (Aripiprazole, Risperidone, Paliperidone, Zotepine)
|
Serotonergics
|
[[[:Template:Fullurl:Template:]] v]·[[[:Template:Fullurl:Template talk:]] d]·[[[:Template:Fullurl:Template:]] e] 5-HT1 receptor ligands
|
|
|
|
Agonists: Azapirones: Alnespirone • Binospirone • Buspirone • Enilospirone • Eptapirone • Gepirone • Ipsapirone • Perospirone • Revospirone • Tandospirone • Tiospirone • Umespirone • Zalospirone; Antidepressants: Etoperidone • Nefazodone • Trazodone; Antipsychotics: Aripiprazole • Asenapine • Clozapine • Quetiapine • Ziprasidone; Ergolines: Dihydroergotamine • Ergotamine • Lisuride • Methysergide • LSD; Tryptamines: 5-CT • 5-MeO-DMT • 5-MT • Bufotenin • DMT • Indorenate • Psilocin • Psilocybin; Others: 8-OH-DPAT • Adatanserin • Befiradol • BMY-14802 • Cannabidiol • Dimemebfe • Ebalzotan • Eltoprazine • F-11,461 • F-12,826 • F-13,714 • F-14,679 • F-15,063 • F-15,599 • Flesinoxan • Flibanserin • Lesopitron • Lu AA21004 • LY-293,284 • LY-301,317 • MKC-242 • NBUMP • Osemozotan • Oxaflozane • Pardoprunox • Piclozotan • Rauwolscine • Repinotan • Roxindole • RU-24,969 • S 14,506 • S-14,671 • S-15,535 • Sarizotan • SSR-181,507 • Sunepitron • U-92,016-A • Urapidil • Vilazodone • Xaliproden • Yohimbine Antagonists: Antipsychotics: Iloperidone • Risperidone • Sertindole; Beta blockers: Alprenolol • Cyanopindolol • Iodocyanopindolol • Oxprenolol • Pindobind • Pindolol • Propranolol • Tertatolol; Others: AV965 • BMY-7,378 • CSP-2503 • Dotarizine • Flopropione • GR-46611 • Isamoltane • Lecozotan • Mefway • Metitepine/Methiothepin • MPPF • NAN-190 • PRX-00023 • Robalzotan • S-15535 • SB-649,915 • SDZ 216-525 • Spiperone • Spiramide • Spiroxatrine • UH-301 • WAY-100,135 • WAY-100,635 • Xylamidine
|
|
|
Agonists: Lysergamides: Dihydroergotamine • Ergotamine • Methysergide; Piperazines: Eltoprazine • TFMPP; Triptans: Avitriptan • Eletriptan • Sumatriptan • Zolmitriptan; Tryptamines: 5-CT • 5-MT; Others: CGS-12066A • CP-93,129 • CP-94,253 • CP-135,807 • RU-24,969 Antagonists: Lysergamides: Metergoline; Others: AR-A000002 • Elzasonan • GR-127,935 • Isamoltane • Metitepine/Methiothepin • SB-216,641 • SB-224,289 • SB-236,057 • Yohimbine
|
|
|
Agonists: Lysergamides: Dihydroergotamine • Methysergide; Triptans: Almotriptan • Avitriptan • Eletriptan • Frovatriptan • Naratriptan • Rizatriptan • Sumatriptan • Zolmitriptan; Tryptamines: 5-CT • 5-Ethyl-DMT • 5-MT • 5-(Nonyloxy)tryptamine; Others: CP-135,807 • CP-286,601 • GR-46611 • L-694,247 • L-772,405 • PNU-109,291 • PNU-142,633 Antagonists: Lysergamides: Metergoline; Others: Alniditan • BRL-15,572 • Elzasonan • GR-127,935 • Ketanserin • LY-310,762 • LY-367,642 • LY-456,219 • LY-456,220 • Metitepine/Methiothepin • Ritanserin • Yohimbine • Ziprasidone
|
|
|
Agonists: Lysergamides: Methysergide; Triptans: Eletriptan; Tryptamines: BRL-54443 • Tryptamine Antagonists: Metitepine/Methiothepin
|
|
|
Agonists: Triptans: Eletriptan • Naratriptan • Sumatriptan; Tryptamines: 5-MT; Others: BRL-54443 • Lasmiditan • LY-334,370 Antagonists: Metitepine/Methiothepin
|
|
|
[[[:Template:Fullurl:Template:]] v]·[[[:Template:Fullurl:Template talk:]] d]·[[[:Template:Fullurl:Template:]] e] 5-HT2 receptor ligands
|
|
|
|
Agonists: Lysergamides: ALD-52 • Ergometrine • Lisuride • LA-SS-Az • LSD • LSD-Pip • Lysergic acid 2-butyl amide • Lysergic acid 3-pentyl amide • Methysergide; Phenethylamines: 25I-NBF • 25I-NBMD • 25I-NBOH • 25I-NBOMe • 2C-B • 2C-B-FLY • 2CB-Ind • 2C-C-NBOMe • 2C-E • 2C-I • 2C-TFM-NBOMe • 2C-T-2 • 2C-T-7 • 2C-T-21 • 2CBCB-NBOMe • 2CBFly-NBOMe • Bromo-DragonFLY • DOB • DOC • DOI • DOM • MDA • MDMA • Mescaline • TCB-2 • TFMFly; Piperazines: BZP • Quipazine • TFMPP; Tryptamines: 5-CT • 5-MeO-α-ET • 5-MeO-α-MT • 5-MeO-DET • 5-MeO-DiPT • 5-MeO-DMT • 5-MeO-DPT • 5-MT • α-ET • α-Methyl-5-HT • α-MT • Bufotenin • DET • DiPT • DMT • DPT • Psilocin • Psilocybin; Others: AL-34662 • AL-37350A • Dimemebfe • Medifoxamine • Oxaflozane • PNU-22394 • RH-34 Antagonists: Atypical antipsychotics: Amperozide • Aripiprazole • Carpipramine • Clocapramine • Clozapine • Gevotroline • Iloperidone • Melperone • Mosapramine • Olanzapine • Paliperidone • Pimozide • Quetiapine • Risperidone • Sertindole • Ziprasidone • Zotepine; Typical antipsychotics: Loxapine • Pipamperone; Antidepressants: Amitriptyline • Amoxapine • Aptazapine • Etoperidone • Mianserin • Mirtazapine • Nefazodone • Trazodone; Others: 5-I-R91150 • AC-90179 • Adatanserin • Altanserin • AMDA • APD-215 • Blonanserin • Cinanserin • CSP-2503 • Cyproheptadine • Deramciclane • Dotarizine • Eplivanserin • Esmirtazapine • Fananserin • Flibanserin • Ketanserin • KML-010 • Lubazodone • Mepiprazole • Metitepine/Methiothepin • Nantenine • Pimavanserin • Pizotifen • Pruvanserin • Rauwolscine • Ritanserin • S-14,671 • Sarpogrelate • Setoperone • Spiperone • Spiramide • SR-46349B • Volinanserin • Xylamidine • Yohimbine
|
|
|
Agonists: Oxazolines: 4-Methylaminorex • Aminorex; Phenethylamines: Chlorphentermine • Cloforex • DOB • DOC • DOI • DOM • Fenfluramine • MDA • MDMA • Norfenfluramine; Tryptamines: 5-CT • 5-MT • α-Methyl-5-HT; Others: BW-723C86 • Cabergoline • mCPP • Pergolide • PNU-22394 • Ro60-0175 Antagonists: Agomelatine • Asenapine • EGIS-7625 • Ketanserin • Lisuride • LY-272,015 • Metitepine/Methiothepin • PRX-08066 • Rauwolscine • Ritanserin • RS-127,445 • Sarpogrelate • SB-200,646 • SB-204,741 • SB-206,553 • SB-215,505 • SB-221,284 • SB-228,357 • SDZ SER-082 • Tegaserod • Yohimbine
|
|
|
Agonists: Phenethylamines: 2C-B • 2C-E • 2C-I • 2C-T-2 • 2C-T-7 • 2C-T-21 • DOB • DOC • DOI • DOM • MDA • MDMA • Mescaline; Piperazines: Aripiprazole • mCPP • TFMPP; Tryptamines: 5-CT • 5-MeO-α-ET • 5-MeO-α-MT • 5-MeO-DET • 5-MeO-DiPT • 5-MeO-DMT • 5-MeO-DPT • 5-MT • α-ET • α-Methyl-5-HT • α-MT • Bufotenin • DET • DiPT • DMT • DPT • Psilocin • Psilocybin; Others: A-372,159 • AL-38022A • CP-809,101 • Dimemebfe • Lorcaserin• Medifoxamine • MK-212 • Org 12,962 • ORG-37,684 • Oxaflozane • PNU-22394 • Ro60-0175 • Ro60-0213 • Vabicaserin • WAY-629 • WAY-161,503 • YM-348 Antagonists: Atypical antipsychotics: Clozapine • Iloperidone • Melperone • Olanzapine • Paliperidone • Pimozide • Quetiapine • Risperidone • Sertindole • Ziprasidone • Zotepine; Typical antipsychotics: Chlorpromazine • Loxapine • Pipamperone; Antidepressants: Agomelatine • Amitriptyline • Amoxapine • Aptazapine • Etoperidone • Fluoxetine • Mianserin • Mirtazapine • Nefazodone • Nortriptyline • Trazodone; Others: Adatanserin • Cinanserin • Cyproheptadine • Deramciclane • Dotarizine • Eltoprazine • Esmirtazapine • FR-260,010 • Ketanserin • Ketotifen • Latrepirdine • Lu AA24530 • Metitepine/Methiothepin • Methysergide • Pizotifen • Ritanserin • RS-102,221 • S-14,671 • SB-200,646 • SB-206,553 • SB-221,284 • SB-228,357 • SB-242,084 • SB-243,213 • SDZ SER-082 • Xylamidine
|
|
|
[[[:Template:Fullurl:Template:]] v]·[[[:Template:Fullurl:Template talk:]] d]·[[[:Template:Fullurl:Template:]] e] 5-HT3, 5-HT4, 5-HT5, 5-HT6, 5-HT7 ligands
|
|
|
|
Agonists: Piperazines: BZP • Quipazine; Tryptamines: 2-Methyl-5-HT • 5-CT; Others: Chlorophenylbiguanide • Butanol • Ethanol • Halothane • Isoflurane • RS-56812 • SR-57,227 • SR-57,227-A • Toluene • Trichloroethane • Trichloroethanol • Trichloroethylene • YM-31636 Antagonists: Antiemetics: AS-8112 • Alosetron • Azasetron • Batanopride • Bemesetron • Cilansetron • Dazopride • Dolasetron • Granisetron • Lerisetron • Ondansetron • Palonosetron • Ramosetron • Renzapride • Tropisetron • Zacopride • Zatosetron; Atypical antipsychotics: Clozapine • Olanzapine • Quetiapine; Tetracyclic antidepressants: Amoxapine • Mianserin • Mirtazapine; Others: CSP-2503 • ICS-205,930 • Lu AA21004 • Lu AA24530 • MDL-72,222 • Memantine • Nitrous Oxide • Ricasetron • Sevoflurane • Thujone • Xenon
|
|
|
Agonists: Gastroprokinetic Agents: Cinitapride • Cisapride • Dazopride • Metoclopramide • Mosapride • Prucalopride • Renzapride • Tegaserod • Velusetrag • Zacopride; Others: 5-MT • BIMU8 • CJ-033,466 • PRX-03140 • RS-67333 • RS-67506 • SL65.0155 • Antagonists: GR-113,808 • GR-125,487 • L-Lysine • Piboserod • RS-39604 • RS-67532 • SB-203,186
|
|
|
Agonists: Lysergamides: Ergotamine • LSD; Tryptamines: 5-CT; Others: Valerenic Acid Antagonists: Asenapine • Latrepirdine • Metitepine/Methiothepin • Ritanserin • SB-699,551 * Note that the 5-HT5B receptor is not functional in humans.
|
|
|
Agonists: Lysergamides: Dihydroergotamine • Ergotamine • Lisuride • LSD • Mesulergine • Metergoline • Methysergide; Tryptamines: 2-Methyl-5-HT • 5-BT • 5-CT • 5-MT • Bufotenin • E-6801 • E-6837 • EMD-386,088 • EMDT • LY-586,713 • N-Methyl-5-HT • Tryptamine; Others: WAY-181,187 • WAY-208,466 Antagonists: Antidepressants: Amitriptyline • Amoxapine • Clomipramine • Doxepin • Mianserin • Nortriptyline; Atypical antipsychotics: Aripiprazole • Asenapine • Clozapine • Fluperlapine • Iloperidone • Olanzapine • Tiospirone; Typical antipsychotics: Chlorpromazine • Loxapine; Others: BGC20-760 • BVT-5182 • BVT-74316 • EGIS-12,233 • GW-742,457 • Ketanserin • Latrepirdine • Lu AE58054 • Metitepine/Methiothepin • MS-245 • PRX-07034 • Ritanserin • Ro04-6790 • Ro 63-0563 • SB-258,585 • SB-271,046 • SB-357,134 • SB-399,885 • SB-742,457
|
|
|
Agonists: Lysergamides: LSD; Tryptamines: 5-CT • 5-MT • Bufotenin; Others: 8-OH-DPAT • AS-19 • Bifeprunox • LP-12 • LP-44 • RU-24,969 • Sarizotan Antagonists: Lysergamides: 2-Bromo-LSD • Bromocriptine • Dihydroergotamine • Ergotamine • Mesulergine • Metergoline • Methysergide; Antidepressants: Amitriptyline • Amoxapine • Clomipramine • Imipramine • Maprotiline • Mianserin; Atypical antipsychotics: Amisulpride • Aripiprazole • Clozapine • Olanzapine • Risperidone • Sertindole • Tiospirone • Ziprasidone • Zotepine; Typical antipsychotics: Chlorpromazine • Loxapine; Others: Butaclamol • EGIS-12,233 • Ketanserin • LY-215,840 • Metitepine/Methiothepin • Pimozide • Ritanserin • SB-258,719 • SB-258,741 • SB-269,970 • SB-656,104 • SB-656,104-A • SB-691,673 • SLV-313 • SLV-314 • Spiperone • SSR-181,507
|
|
|
[[[:Template:Fullurl:Template:]] v]·[[[:Template:Fullurl:Template talk:]] d]·[[[:Template:Fullurl:Template:]] e] Reuptake inhibitors
|
|
|
|
|
[[[:Template:Fullurl:Template:]] v]·[[[:Template:Fullurl:Template talk:]] d]·[[[:Template:Fullurl:Template:]] e] Enzyme inhibitors
|
|
|
|
[[[:Template:Fullurl:Template:]] v]·[[[:Template:Fullurl:Template talk:]] d]·[[[:Template:Fullurl:Template:]] e] Others
|
|
|
|
Dopaminergics
|
[[[:Template:Fullurl:Template:]] v]·[[[:Template:Fullurl:Template talk:]] d]·[[[:Template:Fullurl:Template:]] e] Receptor ligands
|
|
|
|
Adamantanes: Amantadine • Memantine • Rimantadine; Aminotetralins: 7-OH-DPAT • 8-OH-PBZI • Rotigotine • UH-232; Benzazepines: 6-Br-APB • Fenoldopam • SKF-38,393 • SKF-77,434 • SKF-81,297 • SKF-82,958 • SKF-83,959; Ergolines: Bromocriptine • Cabergoline • Dihydroergocryptine • Lisuride • LSD • Pergolide; Dihydrexidine derivatives: 2-OH-NPA • A-86,929 • Ciladopa • Dihydrexidine • Dinapsoline • Dinoxyline • Doxanthrine; Others: A-68,930 • A-77,636 • A-412,997 • ABT-670 • ABT-724 • Aplindore • Apomorphine • Aripiprazole • Bifeprunox • BP-897 • CY-208,243 • Dizocilpine • Etilevodopa • Flibanserin • Ketamine • Melevodopa • Modafinil • Pardoprunox • Phencyclidine • PD-128,907 • PD-168,077 • PF-219,061 • Piribedil • Pramipexole • Propylnorapomorphine • Pukateine • Quinagolide • Quinelorane • Quinpirole • RDS-127 • Ro10-5824 • Ropinirole • Rotigotine • Roxindole • Salvinorin A • SKF-89,145 • Sumanirole • Terguride • Umespirone • WAY-100,635
|
|
|
Typical antipsychotics: Acepromazine • Azaperone • Benperidol • Bromperidol • Clopenthixol • Chlorpromazine • Chlorprothixene • Droperidol • Flupentixol • Fluphenazine • Fluspirilene • Haloperidol • Loxapine • Mesoridazine • Methotrimeprazine • Nemonapride • Penfluridol • Perazine • Periciazine • Perphenazine • Pimozide • Prochlorperazine • Promazine • Sulforidazine • Sulpiride • Sultopride • Thioridazine • Thiothixene • Trifluoperazine • Triflupromazine • Trifluperidol • Zuclopenthixol; Atypical antipsychotics: Amisulpride • Asenapine • Blonanserin • Carpipramine • Clocapramine • Clozapine • Gevotroline • Iloperidone • Lurasidone • Melperone • Molindone • Mosapramine • Ocaperidone • Olanzapine • Paliperidone • Perospirone • Piquindone • Quetiapine • Remoxipride • Risperidone • Sertindole • Tiospirone • Ziprasidone • Zotepine; Antiemetics: AS-8112 • Alizapride • Bromopride • Clebopride • Domperidone • Metoclopramide • Thiethylperazine; Others: Amoxapine • Buspirone • Butaclamol • Ecopipam • EEDQ • Eticlopride • Fananserin • L-745,870 • Nafadotride • Nuciferine • PNU-99,194 • Raclopride • Sarizotan • SB-277,011-A • SCH-23,390 • SKF-83,566 • SKF-83,959 • Sonepiprazole • Spiperone • Spiroxatrine • Stepholidine • Tetrahydropalmatine • Tiapride • UH-232 • Yohimbine
|
|
|
[[[:Template:Fullurl:Template:]] v]·[[[:Template:Fullurl:Template talk:]] d]·[[[:Template:Fullurl:Template:]] e] Reuptake inhibitors
|
|
|
|
[[[:Template:Fullurl:Template:]] v]·[[[:Template:Fullurl:Template talk:]] d]·[[[:Template:Fullurl:Template:]] e] Releasing agents
|
|
Morpholines: Fenbutrazate • Morazone • Phendimetrazine • Phenmetrazine; Oxazolines: 4-Methylaminorex (4-MAR, 4-MAX) • Aminorex • Clominorex • Cyclazodone • Fenozolone • Fluminorex • Pemoline • Thozalinone; Phenethylamines (also amphetamines, cathinones, phentermines, etc): 2-Hydroxyphenethylamine (2-OH-PEA) • 4-CAB • 4-Methylamphetamine (4-MA) • 4-Methylmethamphetamine (4-MMA) • Alfetamine • Amfecloral • Amfepentorex • Amfepramone • Amphetamine (Dextroamphetamine, Levoamphetamine) • Amphetaminil • β-Methylphenethylamine (β-Me-PEA) • Benzodioxolylbutanamine (BDB) • Benzodioxolylhydroxybutanamine (BOH) • Benzphetamine • Buphedrone • Butylone • Cathine • Cathinone • Clobenzorex • Clortermine • D-Deprenyl • Dimethoxyamphetamine (DMA) • Dimethoxymethamphetamine (DMMA) • Dimethylamphetamine • Dimethylcathinone (Dimethylpropion, metamfepramone) • Ethcathinone (Ethylpropion) • Ethylamphetamine • Ethylbenzodioxolylbutanamine (EBDB) • Ethylone • Famprofazone • Fenethylline • Fenproporex • Flephedrone • Fludorex • Furfenorex • Hordenine • Lophophine (Homomyristicylamine) • Mefenorex • Mephedrone • Methamphetamine (Desoxyephedrine, Methedrine; Dextromethamphetamine, Levomethamphetamine) • Methcathinone (Methylpropion) • Methedrone • Methoxymethylenedioxyamphetamine (MMDA) • Methoxymethylenedioxymethamphetamine (MMDMA) • Methylbenzodioxolylbutanamine (MBDB) • Methylenedioxyamphetamine (MDA, tenamfetamine) • Methylenedioxyethylamphetamine (MDEA) • Methylenedioxyhydroxyamphetamine (MDOH) • Methylenedioxymethamphetamine (MDMA) • Methylenedioxymethylphenethylamine (MDMPEA, homarylamine) • Methylenedioxyphenethylamine (MDPEA, homopiperonylamine) • Methylone • Ortetamine • Parabromoamphetamine (PBA) • Parachloroamphetamine (PCA) • Parafluoroamphetamine (PFA) • Parafluoromethamphetamine (PFMA) • Parahydroxyamphetamine (PHA) • Paraiodoamphetamine (PIA) • Paredrine (Norpholedrine, Oxamphetamine) • Phenethylamine (PEA) • Pholedrine • Phenpromethamine • Prenylamine • Propylamphetamine • Tiflorex (Flutiorex) • Tyramine (TRA) • Xylopropamine • Zylofuramine; Piperazines: 2,5-Dimethoxy-4-bromobenzylpiperazine (2C-B-BZP) • Benzylpiperazine (BZP) • Methoxyphenylpiperazine (MeOPP, paraperazine) • Methylbenzylpiperazine (MBZP) • Methylenedioxybenzylpiperazine (MDBZP, piperonylpiperazine); Others: 2-Amino-1,2-dihydronaphthalene (2-ADN) • 2-Aminoindane (2-AI) • 2-Aminotetralin (2-AT) • 4-Benzylpiperidine (4-BP) • 5-IAI • Clofenciclan • Cyclopentamine • Cypenamine • Cyprodenate • Feprosidnine • Gilutensin • Heptaminol • Hexacyclonate • Indanylaminopropane (IAP) • Indanorex • Isometheptene • Methylhexanamine • Naphthylaminopropane (NAP) • Octodrine • Phthalimidopropiophenone • Propylhexedrine (Levopropylhexedrine) • Tuaminoheptane (Tuamine)
|
|
[[[:Template:Fullurl:Template:]] v]·[[[:Template:Fullurl:Template talk:]] d]·[[[:Template:Fullurl:Template:]] e] Enzyme inhibitors
|
|
|
|
[[[:Template:Fullurl:Template:]] v]·[[[:Template:Fullurl:Template talk:]] d]·[[[:Template:Fullurl:Template:]] e] Others
|
|
|
|
Template:Piperazines